Wolfe Research analysts downgraded AbbVie Inc. (NYSE:ABBV) from Outperform to Peer Perform on January 08, 2026.
AbbVie Inc. operates in the Healthcare sector. The stock currently trades at $227.06 with a market capitalization of $395,662,263,610. The stock has gained 24.6% over the past 52 weeks.